Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

While trichomoniasis is the most common curable sexually transmitted disease (STD) in the United States,1 reports of metronidazole-resistant trichomoniasis are increasing. New evidence indicates that tinidazole (Tindamax, Presutti Laboratories, Rolling Meadows, IL), recently introduced in the United States, is an effective therapy for metronidazole-resistant trichomoniasis and is well tolerated even at high doses.

Time to take aim at treating trichomoniasis